Marchou B - Search Results

1

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

Nicot F, Saliou A, Raymond S, Sauné K, Dubois M, Massip P, Marchou B, Delobel P, Izopet J. Nicot F, et al. Among authors: marchou b. J Clin Virol. 2012 Oct;55(2):107-13. doi: 10.1016/j.jcv.2012.06.018. Epub 2012 Jul 20. J Clin Virol. 2012. PMID: 22818969

2

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.

Izopet J, Sailler L, Sandres K, Pasquier C, Bonnet E, Aquilina C, Puel J, Massip P, Marchou B. Izopet J, et al. Among authors: marchou b. J Med Virol. 1999 Feb;57(2):163-8. J Med Virol. 1999. PMID: 9892402 Clinical Trial.

3

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.

Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P. Izopet J, et al. Among authors: marchou b. J Med Virol. 1999 Dec;59(4):507-11. J Med Virol. 1999. PMID: 10534734 Clinical Trial.

4

Minority resistant HIV-1 variants and the response to first-line NNRTI therapy.

Nicot F, Sauné K, Raymond S, Jeanne N, Carcenac R, Lefebvre C, Cuzin L, Marchou B, Delobel P, Izopet J. Nicot F, et al. Among authors: marchou b. J Clin Virol. 2015 Jan;62:20-4. doi: 10.1016/j.jcv.2014.10.020. Epub 2014 Nov 20. J Clin Virol. 2015. PMID: 25542465

5

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.

Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group. Raymond S, et al. Clin Infect Dis. 2018 May 2;66(10):1588-1594. doi: 10.1093/cid/cix1070. Clin Infect Dis. 2018. PMID: 29244143 Free PMC article.

6

Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.

Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Encinas S, Bruel P, Sandres-Sauné K, Marchou B, Massip P, Izopet J. Raymond S, et al. Among authors: marchou b. J Clin Virol. 2010 Feb;47(2):126-30. doi: 10.1016/j.jcv.2009.11.018. Epub 2009 Dec 16. J Clin Virol. 2010. PMID: 20015684

7

Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing.

Raymond S, Saliou A, Nicot F, Delobel P, Dubois M, Cazabat M, Sandres-Sauné K, Marchou B, Massip P, Izopet J. Raymond S, et al. Among authors: marchou b. AIDS. 2011 Aug 24;25(13):1668-70. doi: 10.1097/QAD.0b013e3283498305. AIDS. 2011. PMID: 21673557

8

Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure.

Delobel P, Saliou A, Nicot F, Dubois M, Trancart S, Tangre P, Aboulker JP, Taburet AM, Molina JM, Massip P, Marchou B, Izopet J; ANRS 106-Window Study Team. Delobel P, et al. Among authors: marchou b. PLoS One. 2011;6(6):e21655. doi: 10.1371/journal.pone.0021655. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738752 Free PMC article. Clinical Trial.

9

Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence.

Delobel P, Cazabat M, Saliou A, Loiseau C, Coassin L, Raymond S, Requena M, Marchou B, Massip P, Izopet J. Delobel P, et al. Among authors: marchou b. J Antimicrob Chemother. 2013 Nov;68(11):2506-14. doi: 10.1093/jac/dkt249. Epub 2013 Jun 21. J Antimicrob Chemother. 2013. PMID: 23794603

10

Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing.

Raymond S, Saliou A, Nicot F, Delobel P, Dubois M, Carcenac R, Sauné K, Marchou B, Massip P, Izopet J. Raymond S, et al. Among authors: marchou b. J Antimicrob Chemother. 2013 Dec;68(12):2875-81. doi: 10.1093/jac/dkt290. Epub 2013 Jul 18. J Antimicrob Chemother. 2013. PMID: 23869053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page